enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Powerful new obesity drug poised to upend weight loss care - AOL

   www.aol.com/news/powerful-obesity-drug-poised...

   Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their ...

3. Novo Nordisk cuts Wegovy prices, following similar move by ...

   www.aol.com/novo-nordisk-cuts-wegovy-prices...

   Novo said the new pricing is available to both the uninsured and people who have insurance that doesn't cover the weight-loss drugs. Last week, Eli Lilly said it would cut the monthly price of its ...

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   In May 2010, the U.S. Food and Drug Administration (FDA) approved a revised label for Xenical to include new safety information about rare cases of severe liver injury that have been reported with the use of this medication. [33] A 2010 phase 2 trial found cetilistat significantly reduced weight and was better tolerated than orlistat. [34]

5. Eli Lilly obesity drug now available in US pharmacies - AOL

   www.aol.com/news/eli-lillys-obesity-drug-now...

   Wall Street analysts expect sales of Zepbound to reach about $2 billion in 2024, and for sales of Novo Nordisk's rival obesity drug Wegovy to hit around $7.5 billion.

6. Novo Nordisk expands AI partnership with Valo Health for ...

   www.aol.com/news/novo-nordisk-expands-ai...

   Analysts estimate the obesity drug market would be worth $150 billion in the next decade. CONTEXT Novo and Valo originally partnered in September 2023 in an agreement to develop up to 11 drugs.

7. A Novo Nordisk weight loss drug lowers BMI in kids as ... - AOL

   www.aol.com/news/novo-nordisk-weight-loss-drug...

   In 2023, the American Academy of Pediatrics released new guidelines for treating childhood obesity, recommending for the first time weight loss drugs and, in some cases, surgery for children ages ...

8. JPM's annual healthcare conference: Here's what's next ... - AOL

   www.aol.com/finance/jpms-annual-healthcare...

   GLP-1s are the dominant treatment for the new obesity market, led by Novo's Wegovy and Eli Lilly's newly approved Zepbound. Investors are waiting to see how the companies compete with each other ...

9. So, you've lost weight using Wegovy. Does that mean you ... - AOL

   www.aol.com/news/youve-lost-weight-using-wegovy...

   Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? More than 3 million ...